A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs

  title={A new trend in drugs-of-abuse; the 2C-series of phenethylamine designer drugs},
  author={Douwe de Boer and Ingrid Jolanda Bosman},
  journal={Pharmacy World and Science},
  • D. de BoerI. Bosman
  • Published 1 April 2004
  • Medicine, Political Science
  • Pharmacy World and Science
Objective: To collect data related to phenethylamine drugs-of-abuse of the 2C-series, to review possible health risks of their use and to discuss legal counter actions of authorities in the European Union (EU).Settings: Dutch smartshops.Methods: In the period of 1994–2002, all products that were claimed to contain synthetic drugs and sold in the smartshops, were purchased. The contents were analysed using analytical chemical technologies such as gas chromatography/mass spectrometry and nuclear… 

Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry.

This paper describes a method for screening and simultaneous quantification of the above-mentioned compounds and their analog mescaline in human blood plasma and was fully validated according to international guidelines.

Bioanalysis of new designer drugs.

This review provides an overview of the developed bioanalytical and analytical methods, the matrices used, sample-preparation procedures, concentration of analytes in case of intoxication and also gives a résumé of immunoassay experiences.

25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers

Substituted phenethylamines are a class of designer drugs that hold a significant position in the drug abuse market. The most important substances within this class appear to be

Metabolism of the designer drug 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in mice, after acute administration.




More data about the new psychoactive drug 2C-B.

The circumstances of the Dutch market that partly confirm the discovery of 2C-B as a new psychoactive phenethylamine in Ecstasy tablets sold on the Swiss black market are reported.

2C-B: a new psychoactive phenylethylamine recently discovered in Ecstasy tablets sold on the Swiss black market.

The amounts of 2C-B found in the tablets were in the range of the minimum quantity required to induce the effects characteristic of this drug.

Structure-activity relationships of the classic hallucinogens and their analogs.

It is of potential value for future research in this area to bring together in a single review the known human potencies of the classic hallucinogens and their analogs.

Para‐methylthioamphetamine, a new amphetamine designer drug of abuse

Toxicological analysis proved that the 'S‐5 tablet' contained para‐methylthioamphetamine (MTA), mainly, which is a relative unknown amphetamine designer drug, which has only been studied as a model compound in some structure‐activity relationship studies.

Dihydrobenzofuran analogues of hallucinogens. 3. Models of 4-substituted (2,5-dimethoxyphenyl)alkylamine derivatives with rigidified methoxy groups.

The results suggest that the dihydrofuran rings in these new analogues effectively model the active binding conformations of the methoxy groups of the parent compounds 1 and 2.

Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users.

The psychoactive agent N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) was identified in urine samples from ten people suspected of petty drug offences, and appears to be the first report on MBDB as an abused drug in Sweden.

Recent paramethoxyamphetamine deaths

Paramethoxyamphetamine (PMA) is a methoxylated phenethylamine derivative that has been used illicitly in Australia since late 1994. It is purportedly sold under the guise of "ecstasy", which is the

In vivo metabolism of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in the rat: identification of urinary metabolites.

The findings suggest that at least two metabolic pathways for 2C-B are operative in rats, and the first pathway leads to the corresponding aldehyde metabolite by deamination, which is subsequently reduced or oxidized, to give the corresponding alcohol and carboxylic acid metabolites.

Update on Clandestine Amphetamines and Their Analogues Recently Seen in Japan

This minireview presents an update on the amphetamines and their analogues by focusing on clandestine tablets encountered in Japan recently, mainly among juveniles.